Pharma & Healthcare
Global Inhalational Isoflurane Market Research Report 2026
- Feb 24, 26
- ID: 721172
- Pages: 110
- Figures: 109
- Views: 6
This report delivers a comprehensive overview of the global Inhalational Isoflurane market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Inhalational Isoflurane. The Inhalational Isoflurane market size, estimates, and forecasts are provided in terms of sales volume (K Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Inhalational Isoflurane market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Inhalational Isoflurane manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
KALBE PHARMA
Baxter
Neon Laboratories
AbbVie
Piramal
LAB UNKNOWN
Viatris
PT Novell Pharmaceutical
Sedana Medical
Lunan Beite
Segment by Type
Generic Drugs
Brand Drug
by Application
Hospital
Clinic
Other
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Inhalational Isoflurane manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines Inhalational Isoflurane sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.
The report segments the global Inhalational Isoflurane market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Inhalational Isoflurane manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
KALBE PHARMA
Baxter
Neon Laboratories
AbbVie
Piramal
LAB UNKNOWN
Viatris
PT Novell Pharmaceutical
Sedana Medical
Lunan Beite
Segment by Type
Generic Drugs
Brand Drug
by Application
Hospital
Clinic
Other
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Inhalational Isoflurane manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines Inhalational Isoflurane sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.
1 Inhalational Isoflurane Market Overview
1.1 Product Definition
1.2 Inhalational Isoflurane by Type
1.2.1 Global Inhalational Isoflurane Market Value by Type: 2025 vs 2032
1.2.2 Generic Drugs
1.2.3 Brand Drug
1.3 Inhalational Isoflurane by Application
1.3.1 Global Inhalational Isoflurane Market Value by Application: 2025 vs 2032
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Global Inhalational Isoflurane Market Size Estimates and Forecasts
1.4.1 Global Inhalational Isoflurane Revenue 2021–2032
1.4.2 Global Inhalational Isoflurane Sales 2021–2032
1.4.3 Global Inhalational Isoflurane Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Inhalational Isoflurane Market Competition by Manufacturers
2.1 Global Inhalational Isoflurane Sales Market Share by Manufacturers (2021–2026)
2.2 Global Inhalational Isoflurane Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Inhalational Isoflurane Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Inhalational Isoflurane, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Inhalational Isoflurane, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Inhalational Isoflurane, Product Types and Applications
2.7 Global Key Manufacturers of Inhalational Isoflurane, Date of Entry into the Industry
2.8 Global Inhalational Isoflurane Market Competitive Situation and Trends
2.8.1 Global Inhalational Isoflurane Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Inhalational Isoflurane Players Market Share by Revenue
2.8.3 Global Inhalational Isoflurane Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Inhalational Isoflurane Market Scenario by Region
3.1 Global Inhalational Isoflurane Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Inhalational Isoflurane Sales by Region: 2021–2032
3.2.1 Global Inhalational Isoflurane Sales by Region: 2021–2026
3.2.2 Global Inhalational Isoflurane Sales by Region: 2027–2032
3.3 Global Inhalational Isoflurane Revenue by Region: 2021–2032
3.3.1 Global Inhalational Isoflurane Revenue by Region: 2021–2026
3.3.2 Global Inhalational Isoflurane Revenue by Region: 2027–2032
3.4 North America Inhalational Isoflurane Market Facts & Figures by Country
3.4.1 North America Inhalational Isoflurane Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Inhalational Isoflurane Sales by Country (2021–2032)
3.4.3 North America Inhalational Isoflurane Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Inhalational Isoflurane Market Facts & Figures by Country
3.5.1 Europe Inhalational Isoflurane Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Inhalational Isoflurane Sales by Country (2021–2032)
3.5.3 Europe Inhalational Isoflurane Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Inhalational Isoflurane Market Facts & Figures by Region
3.6.1 Asia Pacific Inhalational Isoflurane Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Inhalational Isoflurane Sales by Region (2021–2032)
3.6.3 Asia Pacific Inhalational Isoflurane Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Inhalational Isoflurane Market Facts & Figures by Country
3.7.1 Latin America Inhalational Isoflurane Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Inhalational Isoflurane Sales by Country (2021–2032)
3.7.3 Latin America Inhalational Isoflurane Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Inhalational Isoflurane Market Facts & Figures by Country
3.8.1 Middle East and Africa Inhalational Isoflurane Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Inhalational Isoflurane Sales by Country (2021–2032)
3.8.3 Middle East and Africa Inhalational Isoflurane Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Inhalational Isoflurane Sales by Type (2021–2032)
4.1.1 Global Inhalational Isoflurane Sales by Type (2021–2026)
4.1.2 Global Inhalational Isoflurane Sales by Type (2027–2032)
4.1.3 Global Inhalational Isoflurane Sales Market Share by Type (2021–2032)
4.2 Global Inhalational Isoflurane Revenue by Type (2021–2032)
4.2.1 Global Inhalational Isoflurane Revenue by Type (2021–2026)
4.2.2 Global Inhalational Isoflurane Revenue by Type (2027–2032)
4.2.3 Global Inhalational Isoflurane Revenue Market Share by Type (2021–2032)
4.3 Global Inhalational Isoflurane Price by Type (2021–2032)
5 Segment by Application
5.1 Global Inhalational Isoflurane Sales by Application (2021–2032)
5.1.1 Global Inhalational Isoflurane Sales by Application (2021–2026)
5.1.2 Global Inhalational Isoflurane Sales by Application (2027–2032)
5.1.3 Global Inhalational Isoflurane Sales Market Share by Application (2021–2032)
5.2 Global Inhalational Isoflurane Revenue by Application (2021–2032)
5.2.1 Global Inhalational Isoflurane Revenue by Application (2021–2026)
5.2.2 Global Inhalational Isoflurane Revenue by Application (2027–2032)
5.2.3 Global Inhalational Isoflurane Revenue Market Share by Application (2021–2032)
5.3 Global Inhalational Isoflurane Price by Application (2021–2032)
6 Key Companies Profiled
6.1 KALBE PHARMA
6.1.1 KALBE PHARMA Company Information
6.1.2 KALBE PHARMA Description and Business Overview
6.1.3 KALBE PHARMA Inhalational Isoflurane Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 KALBE PHARMA Inhalational Isoflurane Product Portfolio
6.1.5 KALBE PHARMA Recent Developments/Updates
6.2 Baxter
6.2.1 Baxter Company Information
6.2.2 Baxter Description and Business Overview
6.2.3 Baxter Inhalational Isoflurane Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Baxter Inhalational Isoflurane Product Portfolio
6.2.5 Baxter Recent Developments/Updates
6.3 Neon Laboratories
6.3.1 Neon Laboratories Company Information
6.3.2 Neon Laboratories Description and Business Overview
6.3.3 Neon Laboratories Inhalational Isoflurane Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Neon Laboratories Inhalational Isoflurane Product Portfolio
6.3.5 Neon Laboratories Recent Developments/Updates
6.4 AbbVie
6.4.1 AbbVie Company Information
6.4.2 AbbVie Description and Business Overview
6.4.3 AbbVie Inhalational Isoflurane Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 AbbVie Inhalational Isoflurane Product Portfolio
6.4.5 AbbVie Recent Developments/Updates
6.5 Piramal
6.5.1 Piramal Company Information
6.5.2 Piramal Description and Business Overview
6.5.3 Piramal Inhalational Isoflurane Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Piramal Inhalational Isoflurane Product Portfolio
6.5.5 Piramal Recent Developments/Updates
6.6 LAB UNKNOWN
6.6.1 LAB UNKNOWN Company Information
6.6.2 LAB UNKNOWN Description and Business Overview
6.6.3 LAB UNKNOWN Inhalational Isoflurane Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 LAB UNKNOWN Inhalational Isoflurane Product Portfolio
6.6.5 LAB UNKNOWN Recent Developments/Updates
6.7 Viatris
6.7.1 Viatris Company Information
6.7.2 Viatris Description and Business Overview
6.7.3 Viatris Inhalational Isoflurane Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Viatris Inhalational Isoflurane Product Portfolio
6.7.5 Viatris Recent Developments/Updates
6.8 PT Novell Pharmaceutical
6.8.1 PT Novell Pharmaceutical Company Information
6.8.2 PT Novell Pharmaceutical Description and Business Overview
6.8.3 PT Novell Pharmaceutical Inhalational Isoflurane Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 PT Novell Pharmaceutical Inhalational Isoflurane Product Portfolio
6.8.5 PT Novell Pharmaceutical Recent Developments/Updates
6.9 Sedana Medical
6.9.1 Sedana Medical Company Information
6.9.2 Sedana Medical Description and Business Overview
6.9.3 Sedana Medical Inhalational Isoflurane Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 Sedana Medical Inhalational Isoflurane Product Portfolio
6.9.5 Sedana Medical Recent Developments/Updates
6.10 Lunan Beite
6.10.1 Lunan Beite Company Information
6.10.2 Lunan Beite Description and Business Overview
6.10.3 Lunan Beite Inhalational Isoflurane Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 Lunan Beite Inhalational Isoflurane Product Portfolio
6.10.5 Lunan Beite Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Inhalational Isoflurane Industry Chain Analysis
7.2 Inhalational Isoflurane Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Inhalational Isoflurane Production Mode & Process Analysis
7.4 Inhalational Isoflurane Sales and Marketing
7.4.1 Inhalational Isoflurane Sales Channels
7.4.2 Inhalational Isoflurane Distributors
7.5 Inhalational Isoflurane Customer Analysis
8 Inhalational Isoflurane Market Dynamics
8.1 Inhalational Isoflurane Industry Trends
8.2 Inhalational Isoflurane Market Drivers
8.3 Inhalational Isoflurane Market Challenges
8.4 Inhalational Isoflurane Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
1.1 Product Definition
1.2 Inhalational Isoflurane by Type
1.2.1 Global Inhalational Isoflurane Market Value by Type: 2025 vs 2032
1.2.2 Generic Drugs
1.2.3 Brand Drug
1.3 Inhalational Isoflurane by Application
1.3.1 Global Inhalational Isoflurane Market Value by Application: 2025 vs 2032
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Global Inhalational Isoflurane Market Size Estimates and Forecasts
1.4.1 Global Inhalational Isoflurane Revenue 2021–2032
1.4.2 Global Inhalational Isoflurane Sales 2021–2032
1.4.3 Global Inhalational Isoflurane Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Inhalational Isoflurane Market Competition by Manufacturers
2.1 Global Inhalational Isoflurane Sales Market Share by Manufacturers (2021–2026)
2.2 Global Inhalational Isoflurane Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Inhalational Isoflurane Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Inhalational Isoflurane, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Inhalational Isoflurane, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Inhalational Isoflurane, Product Types and Applications
2.7 Global Key Manufacturers of Inhalational Isoflurane, Date of Entry into the Industry
2.8 Global Inhalational Isoflurane Market Competitive Situation and Trends
2.8.1 Global Inhalational Isoflurane Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Inhalational Isoflurane Players Market Share by Revenue
2.8.3 Global Inhalational Isoflurane Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Inhalational Isoflurane Market Scenario by Region
3.1 Global Inhalational Isoflurane Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Inhalational Isoflurane Sales by Region: 2021–2032
3.2.1 Global Inhalational Isoflurane Sales by Region: 2021–2026
3.2.2 Global Inhalational Isoflurane Sales by Region: 2027–2032
3.3 Global Inhalational Isoflurane Revenue by Region: 2021–2032
3.3.1 Global Inhalational Isoflurane Revenue by Region: 2021–2026
3.3.2 Global Inhalational Isoflurane Revenue by Region: 2027–2032
3.4 North America Inhalational Isoflurane Market Facts & Figures by Country
3.4.1 North America Inhalational Isoflurane Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Inhalational Isoflurane Sales by Country (2021–2032)
3.4.3 North America Inhalational Isoflurane Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Inhalational Isoflurane Market Facts & Figures by Country
3.5.1 Europe Inhalational Isoflurane Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Inhalational Isoflurane Sales by Country (2021–2032)
3.5.3 Europe Inhalational Isoflurane Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Inhalational Isoflurane Market Facts & Figures by Region
3.6.1 Asia Pacific Inhalational Isoflurane Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Inhalational Isoflurane Sales by Region (2021–2032)
3.6.3 Asia Pacific Inhalational Isoflurane Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Inhalational Isoflurane Market Facts & Figures by Country
3.7.1 Latin America Inhalational Isoflurane Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Inhalational Isoflurane Sales by Country (2021–2032)
3.7.3 Latin America Inhalational Isoflurane Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Inhalational Isoflurane Market Facts & Figures by Country
3.8.1 Middle East and Africa Inhalational Isoflurane Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Inhalational Isoflurane Sales by Country (2021–2032)
3.8.3 Middle East and Africa Inhalational Isoflurane Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Inhalational Isoflurane Sales by Type (2021–2032)
4.1.1 Global Inhalational Isoflurane Sales by Type (2021–2026)
4.1.2 Global Inhalational Isoflurane Sales by Type (2027–2032)
4.1.3 Global Inhalational Isoflurane Sales Market Share by Type (2021–2032)
4.2 Global Inhalational Isoflurane Revenue by Type (2021–2032)
4.2.1 Global Inhalational Isoflurane Revenue by Type (2021–2026)
4.2.2 Global Inhalational Isoflurane Revenue by Type (2027–2032)
4.2.3 Global Inhalational Isoflurane Revenue Market Share by Type (2021–2032)
4.3 Global Inhalational Isoflurane Price by Type (2021–2032)
5 Segment by Application
5.1 Global Inhalational Isoflurane Sales by Application (2021–2032)
5.1.1 Global Inhalational Isoflurane Sales by Application (2021–2026)
5.1.2 Global Inhalational Isoflurane Sales by Application (2027–2032)
5.1.3 Global Inhalational Isoflurane Sales Market Share by Application (2021–2032)
5.2 Global Inhalational Isoflurane Revenue by Application (2021–2032)
5.2.1 Global Inhalational Isoflurane Revenue by Application (2021–2026)
5.2.2 Global Inhalational Isoflurane Revenue by Application (2027–2032)
5.2.3 Global Inhalational Isoflurane Revenue Market Share by Application (2021–2032)
5.3 Global Inhalational Isoflurane Price by Application (2021–2032)
6 Key Companies Profiled
6.1 KALBE PHARMA
6.1.1 KALBE PHARMA Company Information
6.1.2 KALBE PHARMA Description and Business Overview
6.1.3 KALBE PHARMA Inhalational Isoflurane Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 KALBE PHARMA Inhalational Isoflurane Product Portfolio
6.1.5 KALBE PHARMA Recent Developments/Updates
6.2 Baxter
6.2.1 Baxter Company Information
6.2.2 Baxter Description and Business Overview
6.2.3 Baxter Inhalational Isoflurane Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Baxter Inhalational Isoflurane Product Portfolio
6.2.5 Baxter Recent Developments/Updates
6.3 Neon Laboratories
6.3.1 Neon Laboratories Company Information
6.3.2 Neon Laboratories Description and Business Overview
6.3.3 Neon Laboratories Inhalational Isoflurane Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Neon Laboratories Inhalational Isoflurane Product Portfolio
6.3.5 Neon Laboratories Recent Developments/Updates
6.4 AbbVie
6.4.1 AbbVie Company Information
6.4.2 AbbVie Description and Business Overview
6.4.3 AbbVie Inhalational Isoflurane Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 AbbVie Inhalational Isoflurane Product Portfolio
6.4.5 AbbVie Recent Developments/Updates
6.5 Piramal
6.5.1 Piramal Company Information
6.5.2 Piramal Description and Business Overview
6.5.3 Piramal Inhalational Isoflurane Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Piramal Inhalational Isoflurane Product Portfolio
6.5.5 Piramal Recent Developments/Updates
6.6 LAB UNKNOWN
6.6.1 LAB UNKNOWN Company Information
6.6.2 LAB UNKNOWN Description and Business Overview
6.6.3 LAB UNKNOWN Inhalational Isoflurane Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 LAB UNKNOWN Inhalational Isoflurane Product Portfolio
6.6.5 LAB UNKNOWN Recent Developments/Updates
6.7 Viatris
6.7.1 Viatris Company Information
6.7.2 Viatris Description and Business Overview
6.7.3 Viatris Inhalational Isoflurane Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Viatris Inhalational Isoflurane Product Portfolio
6.7.5 Viatris Recent Developments/Updates
6.8 PT Novell Pharmaceutical
6.8.1 PT Novell Pharmaceutical Company Information
6.8.2 PT Novell Pharmaceutical Description and Business Overview
6.8.3 PT Novell Pharmaceutical Inhalational Isoflurane Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 PT Novell Pharmaceutical Inhalational Isoflurane Product Portfolio
6.8.5 PT Novell Pharmaceutical Recent Developments/Updates
6.9 Sedana Medical
6.9.1 Sedana Medical Company Information
6.9.2 Sedana Medical Description and Business Overview
6.9.3 Sedana Medical Inhalational Isoflurane Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 Sedana Medical Inhalational Isoflurane Product Portfolio
6.9.5 Sedana Medical Recent Developments/Updates
6.10 Lunan Beite
6.10.1 Lunan Beite Company Information
6.10.2 Lunan Beite Description and Business Overview
6.10.3 Lunan Beite Inhalational Isoflurane Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 Lunan Beite Inhalational Isoflurane Product Portfolio
6.10.5 Lunan Beite Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Inhalational Isoflurane Industry Chain Analysis
7.2 Inhalational Isoflurane Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Inhalational Isoflurane Production Mode & Process Analysis
7.4 Inhalational Isoflurane Sales and Marketing
7.4.1 Inhalational Isoflurane Sales Channels
7.4.2 Inhalational Isoflurane Distributors
7.5 Inhalational Isoflurane Customer Analysis
8 Inhalational Isoflurane Market Dynamics
8.1 Inhalational Isoflurane Industry Trends
8.2 Inhalational Isoflurane Market Drivers
8.3 Inhalational Isoflurane Market Challenges
8.4 Inhalational Isoflurane Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Inhalational Isoflurane Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Inhalational Isoflurane Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global Inhalational Isoflurane Market Competitive Situation by Manufacturers in 2025
Table 4. Global Inhalational Isoflurane Sales (K Units) of Key Manufacturers (2021–2026)
Table 5. Global Inhalational Isoflurane Sales Market Share by Manufacturers (2021–2026)
Table 6. Global Inhalational Isoflurane Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global Inhalational Isoflurane Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market Inhalational Isoflurane Average Price (US$/Unit) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of Inhalational Isoflurane, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of Inhalational Isoflurane, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of Inhalational Isoflurane, Product Types and Applications
Table 12. Global Key Manufacturers of Inhalational Isoflurane, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Inhalational Isoflurane Companies by Tier (Tier 1, Tier 2, Tier 3), based on Inhalational Isoflurane Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Inhalational Isoflurane Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global Inhalational Isoflurane Sales by Region (K Units), 2021–2026
Table 18. Global Inhalational Isoflurane Sales Market Share by Region (2021–2026)
Table 19. Global Inhalational Isoflurane Sales by Region (K Units), 2027–2032
Table 20. Global Inhalational Isoflurane Sales Market Share by Region (2027–2032)
Table 21. Global Inhalational Isoflurane Revenue by Region (US$ Million), 2021–2026
Table 22. Global Inhalational Isoflurane Revenue Market Share by Region (2021–2026)
Table 23. Global Inhalational Isoflurane Revenue by Region (US$ Million), 2027–2032
Table 24. Global Inhalational Isoflurane Revenue Market Share by Region (2027–2032)
Table 25. North America Inhalational Isoflurane Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America Inhalational Isoflurane Sales by Country (K Units), 2021–2026
Table 27. North America Inhalational Isoflurane Sales by Country (K Units), 2027–2032
Table 28. North America Inhalational Isoflurane Revenue by Country (US$ Million), 2021–2026
Table 29. North America Inhalational Isoflurane Revenue by Country (US$ Million), 2027–2032
Table 30. Europe Inhalational Isoflurane Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe Inhalational Isoflurane Sales by Country (K Units), 2021–2026
Table 32. Europe Inhalational Isoflurane Sales by Country (K Units), 2027–2032
Table 33. Europe Inhalational Isoflurane Revenue by Country (US$ Million), 2021–2026
Table 34. Europe Inhalational Isoflurane Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific Inhalational Isoflurane Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific Inhalational Isoflurane Sales by Region (K Units), 2021–2026
Table 37. Asia Pacific Inhalational Isoflurane Sales by Region (K Units), 2027–2032
Table 38. Asia Pacific Inhalational Isoflurane Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific Inhalational Isoflurane Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America Inhalational Isoflurane Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America Inhalational Isoflurane Sales by Country (K Units), 2021–2026
Table 42. Latin America Inhalational Isoflurane Sales by Country (K Units), 2027–2032
Table 43. Latin America Inhalational Isoflurane Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America Inhalational Isoflurane Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa Inhalational Isoflurane Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa Inhalational Isoflurane Sales by Country (K Units), 2021–2026
Table 47. Middle East and Africa Inhalational Isoflurane Sales by Country (K Units), 2027–2032
Table 48. Middle East and Africa Inhalational Isoflurane Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa Inhalational Isoflurane Revenue by Country (US$ Million), 2027–2032
Table 50. Global Inhalational Isoflurane Sales (K Units) by Type (2021–2026)
Table 51. Global Inhalational Isoflurane Sales (K Units) by Type (2027–2032)
Table 52. Global Inhalational Isoflurane Sales Market Share by Type (2021–2026)
Table 53. Global Inhalational Isoflurane Sales Market Share by Type (2027–2032)
Table 54. Global Inhalational Isoflurane Revenue (US$ Million) by Type (2021–2026)
Table 55. Global Inhalational Isoflurane Revenue (US$ Million) by Type (2027–2032)
Table 56. Global Inhalational Isoflurane Revenue Market Share by Type (2021–2026)
Table 57. Global Inhalational Isoflurane Revenue Market Share by Type (2027–2032)
Table 58. Global Inhalational Isoflurane Price (US$/Unit) by Type (2021–2026)
Table 59. Global Inhalational Isoflurane Price (US$/Unit) by Type (2027–2032)
Table 60. Global Inhalational Isoflurane Sales (K Units) by Application (2021–2026)
Table 61. Global Inhalational Isoflurane Sales (K Units) by Application (2027–2032)
Table 62. Global Inhalational Isoflurane Sales Market Share by Application (2021–2026)
Table 63. Global Inhalational Isoflurane Sales Market Share by Application (2027–2032)
Table 64. Global Inhalational Isoflurane Revenue (US$ Million) by Application (2021–2026)
Table 65. Global Inhalational Isoflurane Revenue (US$ Million) by Application (2027–2032)
Table 66. Global Inhalational Isoflurane Revenue Market Share by Application (2021–2026)
Table 67. Global Inhalational Isoflurane Revenue Market Share by Application (2027–2032)
Table 68. Global Inhalational Isoflurane Price (US$/Unit) by Application (2021–2026)
Table 69. Global Inhalational Isoflurane Price (US$/Unit) by Application (2027–2032)
Table 70. KALBE PHARMA Company Information
Table 71. KALBE PHARMA Description and Business Overview
Table 72. KALBE PHARMA Inhalational Isoflurane Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 73. KALBE PHARMA Inhalational Isoflurane Product
Table 74. KALBE PHARMA Recent Developments/Updates
Table 75. Baxter Company Information
Table 76. Baxter Description and Business Overview
Table 77. Baxter Inhalational Isoflurane Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 78. Baxter Inhalational Isoflurane Product
Table 79. Baxter Recent Developments/Updates
Table 80. Neon Laboratories Company Information
Table 81. Neon Laboratories Description and Business Overview
Table 82. Neon Laboratories Inhalational Isoflurane Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 83. Neon Laboratories Inhalational Isoflurane Product
Table 84. Neon Laboratories Recent Developments/Updates
Table 85. AbbVie Company Information
Table 86. AbbVie Description and Business Overview
Table 87. AbbVie Inhalational Isoflurane Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 88. AbbVie Inhalational Isoflurane Product
Table 89. AbbVie Recent Developments/Updates
Table 90. Piramal Company Information
Table 91. Piramal Description and Business Overview
Table 92. Piramal Inhalational Isoflurane Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 93. Piramal Inhalational Isoflurane Product
Table 94. Piramal Recent Developments/Updates
Table 95. LAB UNKNOWN Company Information
Table 96. LAB UNKNOWN Description and Business Overview
Table 97. LAB UNKNOWN Inhalational Isoflurane Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 98. LAB UNKNOWN Inhalational Isoflurane Product
Table 99. LAB UNKNOWN Recent Developments/Updates
Table 100. Viatris Company Information
Table 101. Viatris Description and Business Overview
Table 102. Viatris Inhalational Isoflurane Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 103. Viatris Inhalational Isoflurane Product
Table 104. Viatris Recent Developments/Updates
Table 105. PT Novell Pharmaceutical Company Information
Table 106. PT Novell Pharmaceutical Description and Business Overview
Table 107. PT Novell Pharmaceutical Inhalational Isoflurane Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 108. PT Novell Pharmaceutical Inhalational Isoflurane Product
Table 109. PT Novell Pharmaceutical Recent Developments/Updates
Table 110. Sedana Medical Company Information
Table 111. Sedana Medical Description and Business Overview
Table 112. Sedana Medical Inhalational Isoflurane Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 113. Sedana Medical Inhalational Isoflurane Product
Table 114. Sedana Medical Recent Developments/Updates
Table 115. Lunan Beite Company Information
Table 116. Lunan Beite Description and Business Overview
Table 117. Lunan Beite Inhalational Isoflurane Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 118. Lunan Beite Inhalational Isoflurane Product
Table 119. Lunan Beite Recent Developments/Updates
Table 120. Key Raw Materials Lists
Table 121. Raw Materials Key Suppliers Lists
Table 122. Inhalational Isoflurane Distributors List
Table 123. Inhalational Isoflurane Customers List
Table 124. Inhalational Isoflurane Market Trends
Table 125. Inhalational Isoflurane Market Drivers
Table 126. Inhalational Isoflurane Market Challenges
Table 127. Inhalational Isoflurane Market Restraints
Table 128. Research Programs/Design for This Report
Table 129. Key Data Information from Secondary Sources
Table 130. Key Data Information from Primary Sources
Table 131. Authors List of This Report
List of Figures
Figure 1. Product Picture of Inhalational Isoflurane
Figure 2. Global Inhalational Isoflurane Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Inhalational Isoflurane Market Share by Type: 2025 & 2032
Figure 4. Generic Drugs Product Picture
Figure 5. Brand Drug Product Picture
Figure 6. Global Inhalational Isoflurane Market Value by Application (US$ Million), 2021–2032
Figure 7. Global Inhalational Isoflurane Market Share by Application: 2025 & 2032
Figure 8. Hospital
Figure 9. Clinic
Figure 10. Other
Figure 11. Global Inhalational Isoflurane Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 12. Global Inhalational Isoflurane Market Size (US$ Million), 2021–2032
Figure 13. Global Inhalational Isoflurane Sales (K Units), 2021–2032
Figure 14. Global Inhalational Isoflurane Average Price (US$/Unit), 2021–2032
Figure 15. Inhalational Isoflurane Report Years Considered
Figure 16. Inhalational Isoflurane Sales Share by Manufacturers in 2025
Figure 17. Global Inhalational Isoflurane Revenue Share by Manufacturers in 2025
Figure 18. Top 5 and Top 10 Global Inhalational Isoflurane Players: Market Share by Revenue in Inhalational Isoflurane in 2025
Figure 19. Inhalational Isoflurane Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 20. Global Inhalational Isoflurane Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 21. North America Inhalational Isoflurane Sales Market Share by Country (2021–2032)
Figure 22. North America Inhalational Isoflurane Revenue Market Share by Country (2021–2032)
Figure 23. United States Inhalational Isoflurane Revenue Growth Rate (US$ Million), 2021–2032
Figure 24. Canada Inhalational Isoflurane Revenue Growth Rate (US$ Million), 2021–2032
Figure 25. Europe Inhalational Isoflurane Sales Market Share by Country (2021–2032)
Figure 26. Europe Inhalational Isoflurane Revenue Market Share by Country (2021–2032)
Figure 27. Germany Inhalational Isoflurane Revenue Growth Rate (US$ Million), 2021–2032
Figure 28. France Inhalational Isoflurane Revenue Growth Rate (US$ Million), 2021–2032
Figure 29. U.K. Inhalational Isoflurane Revenue Growth Rate (US$ Million), 2021–2032
Figure 30. Italy Inhalational Isoflurane Revenue Growth Rate (US$ Million), 2021–2032
Figure 31. Russia Inhalational Isoflurane Revenue Growth Rate (US$ Million), 2021–2032
Figure 32. Asia Pacific Inhalational Isoflurane Sales Market Share by Region (2021–2032)
Figure 33. Asia Pacific Inhalational Isoflurane Revenue Market Share by Region (2021–2032)
Figure 34. China Inhalational Isoflurane Revenue Growth Rate (US$ Million), 2021–2032
Figure 35. Japan Inhalational Isoflurane Revenue Growth Rate (US$ Million), 2021–2032
Figure 36. South Korea Inhalational Isoflurane Revenue Growth Rate (US$ Million), 2021–2032
Figure 37. India Inhalational Isoflurane Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. Australia Inhalational Isoflurane Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. China Taiwan Inhalational Isoflurane Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. Southeast Asia Inhalational Isoflurane Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. Latin America Inhalational Isoflurane Sales Market Share by Country (2021–2032)
Figure 42. Latin America Inhalational Isoflurane Revenue Market Share by Country (2021–2032)
Figure 43. Mexico Inhalational Isoflurane Revenue Growth Rate (US$ Million), 2021–2032
Figure 44. Brazil Inhalational Isoflurane Revenue Growth Rate (US$ Million), 2021–2032
Figure 45. Argentina Inhalational Isoflurane Revenue Growth Rate (US$ Million), 2021–2032
Figure 46. Colombia Inhalational Isoflurane Revenue Growth Rate (US$ Million), 2021–2032
Figure 47. Middle East and Africa Inhalational Isoflurane Sales Market Share by Country (2021–2032)
Figure 48. Middle East and Africa Inhalational Isoflurane Revenue Market Share by Country (2021–2032)
Figure 49. Turkey Inhalational Isoflurane Revenue Growth Rate (US$ Million), 2021–2032
Figure 50. Saudi Arabia Inhalational Isoflurane Revenue Growth Rate (US$ Million), 2021–2032
Figure 51. UAE Inhalational Isoflurane Revenue Growth Rate (US$ Million), 2021–2032
Figure 52. Global Sales Market Share of Inhalational Isoflurane by Type (2021–2032)
Figure 53. Global Revenue Market Share of Inhalational Isoflurane by Type (2021–2032)
Figure 54. Global Inhalational Isoflurane Price (US$/Unit) by Type (2021–2032)
Figure 55. Global Sales Market Share of Inhalational Isoflurane by Application (2021–2032)
Figure 56. Global Revenue Market Share of Inhalational Isoflurane by Application (2021–2032)
Figure 57. Global Inhalational Isoflurane Price (US$/Unit) by Application (2021–2032)
Figure 58. Inhalational Isoflurane Value Chain
Figure 59. Channels of Distribution (Direct Vs Distribution)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
Table 1. Global Inhalational Isoflurane Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Inhalational Isoflurane Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global Inhalational Isoflurane Market Competitive Situation by Manufacturers in 2025
Table 4. Global Inhalational Isoflurane Sales (K Units) of Key Manufacturers (2021–2026)
Table 5. Global Inhalational Isoflurane Sales Market Share by Manufacturers (2021–2026)
Table 6. Global Inhalational Isoflurane Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global Inhalational Isoflurane Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market Inhalational Isoflurane Average Price (US$/Unit) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of Inhalational Isoflurane, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of Inhalational Isoflurane, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of Inhalational Isoflurane, Product Types and Applications
Table 12. Global Key Manufacturers of Inhalational Isoflurane, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Inhalational Isoflurane Companies by Tier (Tier 1, Tier 2, Tier 3), based on Inhalational Isoflurane Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Inhalational Isoflurane Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global Inhalational Isoflurane Sales by Region (K Units), 2021–2026
Table 18. Global Inhalational Isoflurane Sales Market Share by Region (2021–2026)
Table 19. Global Inhalational Isoflurane Sales by Region (K Units), 2027–2032
Table 20. Global Inhalational Isoflurane Sales Market Share by Region (2027–2032)
Table 21. Global Inhalational Isoflurane Revenue by Region (US$ Million), 2021–2026
Table 22. Global Inhalational Isoflurane Revenue Market Share by Region (2021–2026)
Table 23. Global Inhalational Isoflurane Revenue by Region (US$ Million), 2027–2032
Table 24. Global Inhalational Isoflurane Revenue Market Share by Region (2027–2032)
Table 25. North America Inhalational Isoflurane Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America Inhalational Isoflurane Sales by Country (K Units), 2021–2026
Table 27. North America Inhalational Isoflurane Sales by Country (K Units), 2027–2032
Table 28. North America Inhalational Isoflurane Revenue by Country (US$ Million), 2021–2026
Table 29. North America Inhalational Isoflurane Revenue by Country (US$ Million), 2027–2032
Table 30. Europe Inhalational Isoflurane Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe Inhalational Isoflurane Sales by Country (K Units), 2021–2026
Table 32. Europe Inhalational Isoflurane Sales by Country (K Units), 2027–2032
Table 33. Europe Inhalational Isoflurane Revenue by Country (US$ Million), 2021–2026
Table 34. Europe Inhalational Isoflurane Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific Inhalational Isoflurane Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific Inhalational Isoflurane Sales by Region (K Units), 2021–2026
Table 37. Asia Pacific Inhalational Isoflurane Sales by Region (K Units), 2027–2032
Table 38. Asia Pacific Inhalational Isoflurane Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific Inhalational Isoflurane Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America Inhalational Isoflurane Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America Inhalational Isoflurane Sales by Country (K Units), 2021–2026
Table 42. Latin America Inhalational Isoflurane Sales by Country (K Units), 2027–2032
Table 43. Latin America Inhalational Isoflurane Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America Inhalational Isoflurane Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa Inhalational Isoflurane Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa Inhalational Isoflurane Sales by Country (K Units), 2021–2026
Table 47. Middle East and Africa Inhalational Isoflurane Sales by Country (K Units), 2027–2032
Table 48. Middle East and Africa Inhalational Isoflurane Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa Inhalational Isoflurane Revenue by Country (US$ Million), 2027–2032
Table 50. Global Inhalational Isoflurane Sales (K Units) by Type (2021–2026)
Table 51. Global Inhalational Isoflurane Sales (K Units) by Type (2027–2032)
Table 52. Global Inhalational Isoflurane Sales Market Share by Type (2021–2026)
Table 53. Global Inhalational Isoflurane Sales Market Share by Type (2027–2032)
Table 54. Global Inhalational Isoflurane Revenue (US$ Million) by Type (2021–2026)
Table 55. Global Inhalational Isoflurane Revenue (US$ Million) by Type (2027–2032)
Table 56. Global Inhalational Isoflurane Revenue Market Share by Type (2021–2026)
Table 57. Global Inhalational Isoflurane Revenue Market Share by Type (2027–2032)
Table 58. Global Inhalational Isoflurane Price (US$/Unit) by Type (2021–2026)
Table 59. Global Inhalational Isoflurane Price (US$/Unit) by Type (2027–2032)
Table 60. Global Inhalational Isoflurane Sales (K Units) by Application (2021–2026)
Table 61. Global Inhalational Isoflurane Sales (K Units) by Application (2027–2032)
Table 62. Global Inhalational Isoflurane Sales Market Share by Application (2021–2026)
Table 63. Global Inhalational Isoflurane Sales Market Share by Application (2027–2032)
Table 64. Global Inhalational Isoflurane Revenue (US$ Million) by Application (2021–2026)
Table 65. Global Inhalational Isoflurane Revenue (US$ Million) by Application (2027–2032)
Table 66. Global Inhalational Isoflurane Revenue Market Share by Application (2021–2026)
Table 67. Global Inhalational Isoflurane Revenue Market Share by Application (2027–2032)
Table 68. Global Inhalational Isoflurane Price (US$/Unit) by Application (2021–2026)
Table 69. Global Inhalational Isoflurane Price (US$/Unit) by Application (2027–2032)
Table 70. KALBE PHARMA Company Information
Table 71. KALBE PHARMA Description and Business Overview
Table 72. KALBE PHARMA Inhalational Isoflurane Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 73. KALBE PHARMA Inhalational Isoflurane Product
Table 74. KALBE PHARMA Recent Developments/Updates
Table 75. Baxter Company Information
Table 76. Baxter Description and Business Overview
Table 77. Baxter Inhalational Isoflurane Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 78. Baxter Inhalational Isoflurane Product
Table 79. Baxter Recent Developments/Updates
Table 80. Neon Laboratories Company Information
Table 81. Neon Laboratories Description and Business Overview
Table 82. Neon Laboratories Inhalational Isoflurane Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 83. Neon Laboratories Inhalational Isoflurane Product
Table 84. Neon Laboratories Recent Developments/Updates
Table 85. AbbVie Company Information
Table 86. AbbVie Description and Business Overview
Table 87. AbbVie Inhalational Isoflurane Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 88. AbbVie Inhalational Isoflurane Product
Table 89. AbbVie Recent Developments/Updates
Table 90. Piramal Company Information
Table 91. Piramal Description and Business Overview
Table 92. Piramal Inhalational Isoflurane Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 93. Piramal Inhalational Isoflurane Product
Table 94. Piramal Recent Developments/Updates
Table 95. LAB UNKNOWN Company Information
Table 96. LAB UNKNOWN Description and Business Overview
Table 97. LAB UNKNOWN Inhalational Isoflurane Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 98. LAB UNKNOWN Inhalational Isoflurane Product
Table 99. LAB UNKNOWN Recent Developments/Updates
Table 100. Viatris Company Information
Table 101. Viatris Description and Business Overview
Table 102. Viatris Inhalational Isoflurane Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 103. Viatris Inhalational Isoflurane Product
Table 104. Viatris Recent Developments/Updates
Table 105. PT Novell Pharmaceutical Company Information
Table 106. PT Novell Pharmaceutical Description and Business Overview
Table 107. PT Novell Pharmaceutical Inhalational Isoflurane Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 108. PT Novell Pharmaceutical Inhalational Isoflurane Product
Table 109. PT Novell Pharmaceutical Recent Developments/Updates
Table 110. Sedana Medical Company Information
Table 111. Sedana Medical Description and Business Overview
Table 112. Sedana Medical Inhalational Isoflurane Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 113. Sedana Medical Inhalational Isoflurane Product
Table 114. Sedana Medical Recent Developments/Updates
Table 115. Lunan Beite Company Information
Table 116. Lunan Beite Description and Business Overview
Table 117. Lunan Beite Inhalational Isoflurane Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 118. Lunan Beite Inhalational Isoflurane Product
Table 119. Lunan Beite Recent Developments/Updates
Table 120. Key Raw Materials Lists
Table 121. Raw Materials Key Suppliers Lists
Table 122. Inhalational Isoflurane Distributors List
Table 123. Inhalational Isoflurane Customers List
Table 124. Inhalational Isoflurane Market Trends
Table 125. Inhalational Isoflurane Market Drivers
Table 126. Inhalational Isoflurane Market Challenges
Table 127. Inhalational Isoflurane Market Restraints
Table 128. Research Programs/Design for This Report
Table 129. Key Data Information from Secondary Sources
Table 130. Key Data Information from Primary Sources
Table 131. Authors List of This Report
List of Figures
Figure 1. Product Picture of Inhalational Isoflurane
Figure 2. Global Inhalational Isoflurane Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Inhalational Isoflurane Market Share by Type: 2025 & 2032
Figure 4. Generic Drugs Product Picture
Figure 5. Brand Drug Product Picture
Figure 6. Global Inhalational Isoflurane Market Value by Application (US$ Million), 2021–2032
Figure 7. Global Inhalational Isoflurane Market Share by Application: 2025 & 2032
Figure 8. Hospital
Figure 9. Clinic
Figure 10. Other
Figure 11. Global Inhalational Isoflurane Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 12. Global Inhalational Isoflurane Market Size (US$ Million), 2021–2032
Figure 13. Global Inhalational Isoflurane Sales (K Units), 2021–2032
Figure 14. Global Inhalational Isoflurane Average Price (US$/Unit), 2021–2032
Figure 15. Inhalational Isoflurane Report Years Considered
Figure 16. Inhalational Isoflurane Sales Share by Manufacturers in 2025
Figure 17. Global Inhalational Isoflurane Revenue Share by Manufacturers in 2025
Figure 18. Top 5 and Top 10 Global Inhalational Isoflurane Players: Market Share by Revenue in Inhalational Isoflurane in 2025
Figure 19. Inhalational Isoflurane Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 20. Global Inhalational Isoflurane Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 21. North America Inhalational Isoflurane Sales Market Share by Country (2021–2032)
Figure 22. North America Inhalational Isoflurane Revenue Market Share by Country (2021–2032)
Figure 23. United States Inhalational Isoflurane Revenue Growth Rate (US$ Million), 2021–2032
Figure 24. Canada Inhalational Isoflurane Revenue Growth Rate (US$ Million), 2021–2032
Figure 25. Europe Inhalational Isoflurane Sales Market Share by Country (2021–2032)
Figure 26. Europe Inhalational Isoflurane Revenue Market Share by Country (2021–2032)
Figure 27. Germany Inhalational Isoflurane Revenue Growth Rate (US$ Million), 2021–2032
Figure 28. France Inhalational Isoflurane Revenue Growth Rate (US$ Million), 2021–2032
Figure 29. U.K. Inhalational Isoflurane Revenue Growth Rate (US$ Million), 2021–2032
Figure 30. Italy Inhalational Isoflurane Revenue Growth Rate (US$ Million), 2021–2032
Figure 31. Russia Inhalational Isoflurane Revenue Growth Rate (US$ Million), 2021–2032
Figure 32. Asia Pacific Inhalational Isoflurane Sales Market Share by Region (2021–2032)
Figure 33. Asia Pacific Inhalational Isoflurane Revenue Market Share by Region (2021–2032)
Figure 34. China Inhalational Isoflurane Revenue Growth Rate (US$ Million), 2021–2032
Figure 35. Japan Inhalational Isoflurane Revenue Growth Rate (US$ Million), 2021–2032
Figure 36. South Korea Inhalational Isoflurane Revenue Growth Rate (US$ Million), 2021–2032
Figure 37. India Inhalational Isoflurane Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. Australia Inhalational Isoflurane Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. China Taiwan Inhalational Isoflurane Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. Southeast Asia Inhalational Isoflurane Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. Latin America Inhalational Isoflurane Sales Market Share by Country (2021–2032)
Figure 42. Latin America Inhalational Isoflurane Revenue Market Share by Country (2021–2032)
Figure 43. Mexico Inhalational Isoflurane Revenue Growth Rate (US$ Million), 2021–2032
Figure 44. Brazil Inhalational Isoflurane Revenue Growth Rate (US$ Million), 2021–2032
Figure 45. Argentina Inhalational Isoflurane Revenue Growth Rate (US$ Million), 2021–2032
Figure 46. Colombia Inhalational Isoflurane Revenue Growth Rate (US$ Million), 2021–2032
Figure 47. Middle East and Africa Inhalational Isoflurane Sales Market Share by Country (2021–2032)
Figure 48. Middle East and Africa Inhalational Isoflurane Revenue Market Share by Country (2021–2032)
Figure 49. Turkey Inhalational Isoflurane Revenue Growth Rate (US$ Million), 2021–2032
Figure 50. Saudi Arabia Inhalational Isoflurane Revenue Growth Rate (US$ Million), 2021–2032
Figure 51. UAE Inhalational Isoflurane Revenue Growth Rate (US$ Million), 2021–2032
Figure 52. Global Sales Market Share of Inhalational Isoflurane by Type (2021–2032)
Figure 53. Global Revenue Market Share of Inhalational Isoflurane by Type (2021–2032)
Figure 54. Global Inhalational Isoflurane Price (US$/Unit) by Type (2021–2032)
Figure 55. Global Sales Market Share of Inhalational Isoflurane by Application (2021–2032)
Figure 56. Global Revenue Market Share of Inhalational Isoflurane by Application (2021–2032)
Figure 57. Global Inhalational Isoflurane Price (US$/Unit) by Application (2021–2032)
Figure 58. Inhalational Isoflurane Value Chain
Figure 59. Channels of Distribution (Direct Vs Distribution)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Trichosanthes Kirilowii Extract Market Research Report 2026
Feb 24, 26
Global Glass Lined Containers Market Research Report 2026
Feb 24, 26
Global Open End Wrenches Market Research Report 2026
Feb 24, 26
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232